Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03444103Phase 2Completed
A Pilot Trial of Clazakizumab in Late ABMR
Antibody-mediated Rejection
PrincipalinvestigatorStart date: 2018-01-16

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Department of Clinical Pharmacology, Medical University Vienna

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Vivian McAlister

London Health Sciences Center

Moderately Similar
2 trials

Shared therapeutic areas:

Antibody-mediated Rejection
Similarity Score30%

Vincent Pernin, Doctor

UH Montpellier

Moderately Similar
1 trials

Shared therapeutic areas:

Antibody-mediated Rejection
Similarity Score30%

Jignesh Patel, M.D., Ph.D.

Cedars Sinai Medical Center and Heart Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Antibody-mediated Rejection
Similarity Score30%

Juan F Delgado, MD PhD

University Hospital 12 de Octubre

Moderately Similar
1 trials

Shared therapeutic areas:

Antibody-mediated Rejection
Similarity Score30%

Jianyong Wu, MD

First Affiliated Hospital of Zhejiang University

Moderately Similar
1 trials

Shared therapeutic areas:

Antibody-mediated Rejection
Similarity Score30%

Program Director

CSL Behring

Moderately Similar
12 trials

Shared therapeutic areas:

Antibody-mediated Rejection

Worked with same sponsors:

CSL Behring
Similarity Score30%

Yaming Wei, Doctor

Director of Blood Transfusion Department

Moderately Similar
1 trials

Shared therapeutic areas:

Antibody-mediated Rejection
Similarity Score30%

Ramsey R Hachem, MD

Washington University School of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Antibody-mediated Rejection
Similarity Score30%

Georg A Böhmig, MD

Medical University Vienna, Division of Medicine III, Dpt. of Nephrology and Dialysis

Moderately Similar
1 trials

Shared therapeutic areas:

Antibody-mediated Rejection

Worked with same sponsors:

Medical University of Vienna
Similarity Score30%

Shahid Beheshti MU sbmu

Shahid Beheshti University of Medical Sciences

Moderately Similar
1 trials

Shared therapeutic areas:

Antibody-mediated Rejection
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03444103Phase 2PrincipalInvestigator

A Pilot Trial of Clazakizumab in Late ABMR

Antibody-mediated Rejection
Completed

All 1 trials loaded